-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SddQejc/YGGuDpUiTqjFVFPPCnxiUydFXGe/cB2NMmr6T+COY1uJXncsyOzjIGET R7I3zKdIoOoe8FRjEmghOg== 0000816151-96-000017.txt : 19960612 0000816151-96-000017.hdr.sgml : 19960612 ACCESSION NUMBER: 0000816151-96-000017 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960603 ITEM INFORMATION: Other events FILED AS OF DATE: 19960607 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABONE INC CENTRAL INDEX KEY: 0000816151 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 480952323 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-15975 FILM NUMBER: 96577938 BUSINESS ADDRESS: STREET 1: 10310 W 84TH TERR CITY: LENEXA STATE: KS ZIP: 66214 BUSINESS PHONE: 9138888397 MAIL ADDRESS: STREET 1: 10310 W 84TH TERRACE CITY: LENEXA STATE: KS ZIP: 66214 FORMER COMPANY: FORMER CONFORMED NAME: HOME OFFICE REFERENCE LABORATORY INC DATE OF NAME CHANGE: 19940405 8-K 1 SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 1996 LabOne, Inc. ---------------------------------------------------- (Exact name of registrant as specified in its charter) Delaware 0-15975 48-0952323 -------------------- ----------- ------------- (State or other jurisdiction (Commission (I. R. S. Employer of incorporation File Number) Identification No.) 10310 W. 84th Terrace, Lenexa, KS 66214 ---------------------------------------- ------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 913-888-1770 Page 1 of 2 Item 5. Other Events On June 3, 1996, LabOne, Inc., was notified by Epitope, Inc., that the Food and Drug Administration (FDA) had approved the OraSure(Registered) HIV-1 Western Blot Test. LabOne plans to include the oral fluid confirmation test in its standard oral fluid testing services, as soon as the confirmatory test is available for purchase. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. LabOne, Inc. Date: June 7, 1996 By /s/ Kurt E. Gruenbacher ---------------------------- Kurt E. Gruenbacher V.P. Finance and Chief Accounting Officer Date: June 7, 1996 By /s/ Robert D. Thompson ---------------------------- Robert D. Thompson Executive V.P. Finance, CFO and Treasurer Page 2 -----END PRIVACY-ENHANCED MESSAGE-----